Table 1 The expression of NMU in HCC
From: The prognostic value of neuromedin U in patients with hepatocellular carcinoma
| Group | n | Expression of NMU | |
|---|---|---|---|
| Low | High | ||
| Peri-tumor | 228 | 133 (58.3%) | 95 (41.7%) |
| Intra-tumor | 228 | 137 (60.1%) | 91 (39.9%) |
From: The prognostic value of neuromedin U in patients with hepatocellular carcinoma
| Group | n | Expression of NMU | |
|---|---|---|---|
| Low | High | ||
| Peri-tumor | 228 | 133 (58.3%) | 95 (41.7%) |
| Intra-tumor | 228 | 137 (60.1%) | 91 (39.9%) |